The most rigorously studied approach to the prevention of recurrent BV, however, certainly comes from a US multicenter trial in which women were initially treated during the open-labeled phase ...

BV is particularly prevalent among women in ... that 77% of women were satisfied with boric acid treatment for their ...

Astodrimer is under clinical development by Starpharma and currently in Phase I for Coronavirus Disease 2019 (COVID-19).

For recurrent bacterial vaginosis you need to continue taking the probiotic long term because there’s probably a tiny population of the BV-causing bacteria that live dormant in your vagina ...